Page last updated: 2024-08-21

isoxazoles and Abnormalities, Congenital

isoxazoles has been researched along with Abnormalities, Congenital in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abou-Khalil, B; Montouris, G	1
Braddock, SR; Chambers, CD; Jin, S; Johnson, DL; Jones, KL; Lopez-Jimenez, J; Luo, YJ; Mirrasoul, N; Robinson, LK; Salas, E; Xu, R	1
Villiger, PM; von Esebeck, M; Østensen, M	1

Reviews

1 review(s) available for isoxazoles and Abnormalities, Congenital

Article	Year
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Epilepsia, 2009, Volume: 50 Suppl 8 Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Generalized; Female; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Pregnancy; Risk Assessment; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Weight Gain; Zonisamide	2009

Article

Year

The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?

Epilepsia, 2009, Volume: 50 Suppl 8

Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Generalized; Female; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Pregnancy; Risk Assessment; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Weight Gain; Zonisamide

2009

Other Studies

2 other study(ies) available for isoxazoles and Abnormalities, Congenital

Article	Year
Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis and rheumatism, 2010, Volume: 62, Issue:5 Topics: Adult; Anticholesteremic Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Birth Weight; Body Size; Cholestyramine Resin; Congenital Abnormalities; Female; Gestational Age; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Linear Models; Multivariate Analysis; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Risk Factors	2010
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. The Journal of rheumatology, 2007, Volume: 34, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Congenital Abnormalities; Contraception; Contraception Behavior; Female; Health Surveys; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Outcome; Rheumatic Diseases	2007

Article

Year

Birth outcomes in women who have taken leflunomide during pregnancy.

Arthritis and rheumatism, 2010, Volume: 62, Issue:5

Topics: Adult; Anticholesteremic Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Birth Weight; Body Size; Cholestyramine Resin; Congenital Abnormalities; Female; Gestational Age; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Linear Models; Multivariate Analysis; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Risk Factors

2010

Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.

The Journal of rheumatology, 2007, Volume: 34, Issue:6

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Congenital Abnormalities; Contraception; Contraception Behavior; Female; Health Surveys; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Outcome; Rheumatic Diseases

2007